Description
A prodrug of gemcitabine designed for improved oral bioavailability; inhibits the growth of human non-small cell lung cancer NCI-H460 cells, colon cancer HCT116 cells, and breast cancer MCF-7 cells both in vitro (IC50s = 0.78, 0.92, and 0.64 μM, respectively) and in xenograft cancer models
Formal name: N-[(1S)-3-chloro-2-oxo-1-(phenylmethyl)propyl]-carbamic acid, phenylmethyl ester
Synonyms: NSC 251810
Molecular weight: 331.8
CAS: 26049-94-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|DNA Damage and Repair